Antimicrobials and Antimicrobial Resistance: Current and Future Prospects

Dear Colleagues,

As everyone is aware, antimicrobial resistance (AMR) is one of the biggest public health challenges of our time. It has been estimated that each year, at least 700,000 people across the world died from antibiotic-resistant infections. If nothing is done to combat this problem, the figure might reach 10 million people a year by 2050. Fighting this threat is a public health priority that requires a global collaborative approach across different sectors, including medicine, agriculture, and the veterinary sector.

The World Health Organization (WHO) has declared that AMR is one of the top 10 global public health threats facing humanity. The misuse and overuse of antimicrobials are considered the main drivers of the development and spread of drug-resistant pathogens. In addition, lack of clean water and effective infection control measures lead to the further enumeration of microorganisms that are potentially resistant to different antimicrobials. Moreover, the direct and indirect economic losses associated with AMR are significant.

We need to understand that without effective antimicrobials, the success of modern medicine varying from simple interventions (e.g., cesarean section) to complicated ones (major surgery, organ transplantations, etc.) is under increasing risk. Therefore, this Special Issue welcomes submissions related to different aspects of AMR, including epidemiology, surveillance, and analysis of consumption data. Submissions of effective interventions to combat AMR are especially welcome.

Prof. Dr. Roman Kozlov
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.